Docs shocked at revival of UK Medical Innovation Bill
This article was originally published in Scrip
Executive Summary
A controversial private member's bill intended to encourage innovation in medical treatment by offering doctors protection against possible medical negligence litigation is to be discussed again in the House of Lords, even though it had been assumed that the bill was dead in the water after being blocked in the last parliamentary session.
You may also be interested in...
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.
EU Countries Offered Funding To Contribute to African Regulatory Strengthening
Training projects are intended to strengthen the African regulatory environment, boost the capacity of the African Medicines Agency, facilitate regulatory reliance, and increase joint new drug assessments.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.